Precigen Inc reports results for the quarter ended in June - Earnings Summary

Precigen

15/08/2024 05:57

* Precigen Inc  PGEN.OQ  reported a quarterly adjusted loss
of 23
cents​​ per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of -8
cents.  The mean expectation of five analysts for the quarter
was for a loss of 10 cents per share. Wall Street expected
results to range from -10 cents to -9 cents per share.
    * Revenue fell 59.4% to $717.00 thousand from a year ago;
analysts
expected $1.28 million. 
    * Precigen Inc shares had fallen by 31.0% this quarter and
lost 18.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 6.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Precigen Inc is
$10.00 
This summary was machine generated from LSEG data August 15 at
04:57 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.10          -0.23          Missed
 Mar. 31 2024      -0.09          -0.10          Missed
 Dec. 31 2023      -0.08          -0.13          Missed
 Sep. 30 2023      -0.08          -0.08          Met